India's Sun Pharma Loses Bid For Majority Share In Israel's Taro
This article was originally published in PharmAsia News
Executive Summary
India's Sun Pharmaceutical Industries lost an effort to buy a majority share in Israel's Taro Pharmaceutical Industries, in a move that would have taken Taro private.